NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

December 2009 New Drug Updates and Additions

Designation

Brand Name

Generic Name

ABT-869, ABT869, RG3635

 

 Endu, Endostar

KRX-0401, D-21266

 

Perifosine

D-63153, SPI-153

 

Ozarelix

ZEN-115, AEZS-115

 

 

AEZS-120

 

 

ZEN-017, ZEN-012, AEZS-112

 

 

ZEN 027, AEZS-127

 

 

AEZS-126, AEZS-129

 

 

ALN-VSP, ALN-VSP02

 

 

AC220

 

 

ANG1005

 

Paclitaxel

AS1413, NSC 308847

Formerly Xanafide

Amonafide L-malate

ATI-1123-Docetaxel

 

 

BCX-1777

Fodosine

Forodesine hydrochloride

BI-505

 

 

OncoVEX GM-CSF, OncoVEXGMCSF

 

 

BIBF 1120

Vargatef

 

VQD-002, API-2, NSC-154020, VD-0002

 

Triciribine phosphate (TCN-P), triciribine phosphate monohydrate (TCN-PM)

ACE-011

 

 

CEP-701, KT-5555, SPM-924

 

Lestaurtinib

CGX-635, NSC-141633

Omapro (formerly Ceflatonin)

Omacetaxine mepesuccinate

CGX-571, NSC 308847

Quinamed

 

CP-4055

Elacyt

Ara-C, elacytarabine

CP-4200

 

5-Azacitidine (AzaC)

CBLC102

Curaxin

Quinacrine

CGEN-25008

 

 

CGEN-241, CGEN-241A, CGEN-241B

 

 

CGEN-25017

 

 

CYC682 (formerly CS-682)

 

Sapacitabine

CX-3543

 

Quarfloxin

SB-715992 (CK0238273)

 

Ispinesib

SB-743921

 

 

GSK-923295, GSK-923295A, GSK923295A

 

 

LY317615

 

Enzastaurin

LY2181308, ISIS-23722, ISIS 23722

 

 

Acyl sulfonamide anti-proliferative agent (ASAP), LY573636

 

Tasisulam

Trastuzumab-DM1, PRO132365, trastuzumab-MCC-DM1, T-DM1, R3502, RG3502

Herceptin-DM1, Herceptin-MCC-DM1

 

RG1273, R1273, 2C4, rhuMAb-2C4

Omnitarg

Pertuzumab

R1507, RG1507, formerly Roche 1

 

 

XL880, XL-880, GSK1363089, GSK089

 

Foretinib

OP-R003, anti-IL6

Azintrel

 

IMC-1121b, IMC 1121B (previously IMC-1CIIb, IMC-2C6, c-P1C11, IMC-1C11, DC101)

 

Ramucirumab

IMC-11F8

 

Necitumumab

IMC-3G3

 

 

DXL625

 

 

DXL702

 

 

DXLr120

 

 

DXL1218

 

 

JX-594

 

 

AV-951, formerly KRN951

 

Tivozanib

KW-2449

 

 

L-000891675, MK-0752, MK0752

 

 

L-BLP25, BLP-25 (formerly BP1-7-KLH)

Stimuvax

 

R763, AS703569, AS-703569

 

 

MLN0518, MLN518, MLN-518 (formerly CT53518, CT-53518)

 

Tandutinib

MLN8237

 

 

MLN4924

 

 

MLN9708

 

 

MGN1703

dSLIM

 

NKTR-102

 

 

 

DCVax-Prostate, CaPVax

 

 

DCVax-L

 

 

DCVax-Brain

 

PEP-223/CoVaccine HT

 

 

PKC-412, PKC412, CGP41251

 

Midostaurin

 

Reolysin (formerly Reosyn)

 

PX-478

 

 

PX-866, PX866

 

 

PM02734

 

 

NX-473, NX 473 (formerly AMD-473, AMD473, ZD0473)

 

Picoplatin

DI-Leu16-IL2

 

 

R406/R788, R-788, R935788 sodium

 

Fostamatinib disodium

SAR566658

 

 

SGN-40, SGN40 (anti-huCD40 MAb), huS2C6, RG3636

 

Dacetuzumab

SGN-35, SGN35

 

Brentuximab vedotin

STA-9090

 

 

TAK-701, HuL2G7

 

 

TG101348, TG-101348

 

 

OGX-011, ISIS 112989, S TRPM2 ODN

 

Custirsen sodium

C35, VX35

 

 

BVX-20

 

 

VX15

 

 

VNP20009

TAPET (Tumor Amplified Protein Expression Therapy)

 

3-AP, OCX-191, NSC-663249

Triapine

 

VNP40101M, 101M

Onrigin (formerly Cloretazine)

Laromustine

VNP40541 (formerly KS119W)

 

 

ZIO-201, ZIO-201-T

Zymafos

Palifosfamide, isophosphoramide mustard

 

 

Interleukin 21 (IL-21)

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM